8-K: Bristol Myers Squibb Reports First Quarter Financial Results for 2024
Apr 25 07:49 ET
DEFA14A: Others
Apr 22 08:20 ET
Bristol-Myers Squibb | DEFA14A: Others
Mar 28 22:39 ET
Bristol-Myers Squibb | DEF 14A: Definitive information statements
Mar 28 22:39 ET
Bristol-Myers Squibb | 8-K: Gerald Storch Will Not Run for Re-Election to the Board of Directors
Mar 18 17:36 ET
Bristol-Myers Squibb | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Mar 18 17:26 ET
Bristol-Myers Squibb | 8-K: Bristol-Myers Squibb Announces Completion of Acquisition of Karuna Therapeutics
Mar 18 08:59 ET
Bristol-Myers Squibb | 8-K: Collection of Recent Notes Public Offering Announcements
Feb 22 16:19 ET
Bristol-Myers Squibb | 8-K: Bristol-Myers Squibb Appoints Phil Holzer as Senior Vice President and Chief Financial Officer of the Company
Feb 15 17:03 ET
Bristol-Myers Squibb | 8-K: Bristol Myers Squibb Recommends Stockholders Reject Mini-Tender Offer by Tutanota LLC
Feb 14 16:39 ET
Bristol-Myers Squibb | 8-K: Bristol-Myers Squibb Announces Fourth Quarter and Full Year 2023 Financial Results
Feb 2 07:50 ET
Bristol-Myers Squibb | 8-K: Investor presentation of J.P. Morgan Healthcare Conference
Jan 8 00:00 ET
Bristol-Myers Squibb | DFAN14A: Definitive additional proxy soliciting materials filed by non-management
Dec 22, 2023 16:36 ET
Bristol-Myers Squibb | DFAN14A: Definitive additional proxy soliciting materials filed by non-management
Dec 22, 2023 16:21 ET
Bristol-Myers Squibb | 8-K: Bristol-Myers Squibb Have Signed an Agreement and Plan of Merger
Dec 22, 2023 16:15 ET
Bristol-Myers Squibb | 8-K: Current report
Nov 13, 2023 16:19 ET
Bristol-Myers Squibb | 8-K/A: Officers Management Change(Amendment)
Oct 31, 2023 16:30 ET
Bristol-Myers Squibb | 8-K: Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
Oct 26, 2023 07:44 ET
Bristol-Myers Squibb | DFAN14A: Definitive additional proxy soliciting materials filed by non-management
Oct 10, 2023 06:48 ET
Bristol-Myers Squibb | 8-K: Entry into Accelerated Share Repurchase Agreement
Aug 10, 2023 07:10 ET
No Data
No Data